How should I manage a patient with an elevated TSH of 10 mIU/L who is taking 180 µg of Armour Thyroid (desiccated thyroid)?

Management of Elevated TSH (10 mIU/L) on Armour Thyroid 180 mcg

Increase the dose of Armour Thyroid, as this patient is inadequately treated with a TSH of 10 mIU/L despite being on a relatively high dose, indicating either non-compliance, malabsorption, or need for dose escalation. 1

Immediate Assessment

Before adjusting therapy, verify the following:

• Confirm compliance: Failure to respond to 180 mg Armour Thyroid strongly suggests non-compliance or malabsorption 1
• Check timing of medication: Ensure the patient takes thyroid hormone on an empty stomach, away from interfering substances
• Rule out biotin interference: If the patient takes biotin supplements, stop them at least 2 days before retesting TSH, as biotin can cause falsely abnormal thyroid function tests 1
• Repeat thyroid function tests: Obtain TSH, free T4, and total T3 levels to confirm the elevation and assess the T4:T3 ratio 1

Treatment Approach for TSH = 10 mIU/L

For patients already on thyroid hormone replacement with TSH >10 mIU/L, the dose should be adjusted to bring TSH into the reference range. 2 This is not subclinical hypothyroidism in an untreated patient—this is inadequate replacement therapy requiring dose adjustment.

Dose Adjustment Strategy

• Increase Armour Thyroid by 15-30 mg increments 1
• Recheck TSH and thyroid hormones in 6-8 weeks after dose adjustment 1
• Target TSH: Aim for the lower half of the reference range (0.4-2.5 mIU/L), particularly if the patient has persistent hypothyroid symptoms 2, 3
• Monitor for cardiovascular symptoms: Watch for angina, palpitations, or excessive heart rate, which would indicate overtreatment 1

Special Considerations with Armour Thyroid

Potential Issues with Desiccated Thyroid

• Variable T3 content: Armour Thyroid contains both T4 and T3 in a fixed ratio (approximately 4:1), which can lead to supraphysiologic T3 peaks and increased cardiovascular risk 4, 5
• Lack of standardization: The T3 content in desiccated thyroid preparations is less standardized than synthetic levothyroxine 4
• Interference with monitoring: In patients with thyroid cancer history, porcine thyroglobulin in Armour Thyroid can interfere with thyroglobulin monitoring 6

Consider Switching to Levothyroxine

Most guidelines recommend levothyroxine (T4) monotherapy as first-line treatment 2, 7, 3. If the patient insists on continuing Armour Thyroid:

• Ensure they understand the lack of evidence for superiority over levothyroxine 8, 5
• Monitor free T3 levels in addition to TSH and free T4 to avoid T3 toxicity 1
• Watch for signs of hyperthyroidism (tachycardia, weight loss, tremor) 4

Monitoring After Dose Adjustment

• Recheck TSH in 2 months after any dose change 1, 3
• Once stable, monitor TSH annually 3
• Assess for symptoms: If symptoms persist despite normalized TSH, consider other causes rather than further dose escalation 2, 9

Common Pitfalls to Avoid

• Don't ignore TSH = 10 mIU/L: This level requires treatment adjustment, not observation 2
• Don't assume the patient needs a different medication: First confirm compliance and rule out malabsorption 1
• Don't over-suppress TSH: Aim for normal range, not suppressed levels, unless treating thyroid cancer 1
• Don't adjust dose too rapidly in elderly or cardiac patients: Use smaller increments (15 mg) and monitor closely 1